Tech Company Financing Transactions
Iomed Funding Round
On 9/13/2023, Iomed raised $10.7 million in financing from RedSeed, Adara Venture Partners and EASO Ventures.
Transaction Overview
Company Name
Announced On
9/13/2023
Transaction Type
Venture Equity
Amount
$10,670,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand internationally, consolidate its position in the current market, and develop new business models based on its sustainable growth.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
2441 South 3850 West
Salt Lake City, UT 84120
USA
Salt Lake City, UT 84120
USA
Phone
Website
Email Address
Not Recorded
Overview
IOMED, Inc. engages in the development, manufacture, and marketing of drug delivery systems used primarily to treat acute local inflammation in the physical and occupational therapy, and sports medicine markets in the United States and internationally. It offers iontophoresis technology primarily for transdermal drug delivery and for the treatment of ophthalmic disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Lollini
Browse more venture capital transactions:
Prev: 9/13/2023: AuthMind venture capital transaction
Next: 9/13/2023: DeLorean Artificial Intelligence venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs